The predictive value of inflammatory biomarkers for major pathological response in non-small cell lung cancer patients receiving neoadjuvant chemoimmunotherapy and its association with the immune-related tumor microenvironment: a multi-center study

Cancer Immunology, Immunotherapy · Published 2023-03-01 · Available online 3 Sep 2022 · Journal article · DOI 10.1007/s00262-022-03262-w · PMID: 36056951 · PMC · Cited by 60 (Crossref)

Authors (21)

Chongwu Li, Junqi Wu, Long Jiang, Lei Zhang, Jia Huang, Yu Tian, Yue Zhao, Xiucheng Liu, Lang Xia, Haoran E, Peigen Gao, Likun Hou, Minglei Yang, Minjie Ma, Chunxia Su, Hao Zhang, Hezhong Chen, Yunlang She, Dong Xie, Qingquan Luo, Chang Chen

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Volume

72

Issue

3

Pages

783-794

Year

2023

Citation

Li, C., Wu, J., Jiang, L., et al. (2023). The predictive value of inflammatory biomarkers for major pathological response in non-small cell lung cancer patients receiving neoadjuvant chemoimmunotherapy and its association with the immune-related tumor microenvironment: a multi-center study. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-022-03262-w

Related articles

• The Predictive Value of Neutrophil‐To‐Lymphocyte Ratio ( NLR ) for Response to Neoadjuvant Immunochemotherapy in Resectable IIA – IIIB Non‐Small Cell Lung Cancer in Real‐World Practice · Thoracic Cancer · 2026 · Cites or is cited by this article
• VISTA+ neutrophils contribute to platinum resistance by suppressing CD8+T cells in high-grade serous ovarian cancer · Cancer Immunology Research · 2026 · Cites or is cited by this article
• Monocyte-related markers as predictors of immune checkpoint inhibitor efficacy and immune-related adverse events: a systematic review and meta-analysis · Cancer and Metastasis Reviews · 2025 · Cites or is cited by this article
• HBO1 suppresses anti-tumor immunity of CD8⁺ T Cells in thyroid cancer by recruiting BRD4 to regulate VTCN1 expression · Cancer Immunology, Immunotherapy · 2026 · Same journal
• Conserved minimal CD8 cytotoxic immune-state unit in an IL18R1-associated immune program in hepatocellular carcinoma · Cancer Immunology, Immunotherapy · 2026 · Same journal
• Impact of neck nodal yield on immune checkpoint inhibitor outcome after recurrence in head and neck squamous cell carcinoma · Cancer Immunology, Immunotherapy · 2026 · Same journal
• Preclinical efficacy of iPSC-derived MUC1-targeted CAR-NK cells against esophageal squamous cell carcinoma · Cancer Immunology, Immunotherapy · 2026 · Same journal
• Survival outcomes of conversion curative therapy following atezolizumab–bevacizumab in advanced hepatocellular carcinoma · Cancer Immunology, Immunotherapy · 2026 · Same journal
• Integrative single-cell and multi-omics analysis of ZBTB21-mediated serine metabolism in colorectal cancer: from metabolic reprogramming to immune microenvironment modulation · Cancer Immunology, Immunotherapy · 2026 · Same journal
• Squeezing Treatment-Induced Metabolic Alterations in Melanoma Cells Are Accompanied by Impaired Cluster of Differentiation 8-Positive T Cell and Natural Killer Cell Antitumor Effector Functions · Cancer Immunology, Immunotherapy · 2026 · Same journal

Metrics

Citations (Crossref)

60